Texas Prostate Hits 100 TULSA Procedures, Medicare Model Drives 500% Growth
Event summary
- Texas Prostate, led by Dr. James Cochran, completed its 100th TULSA Procedure at Dallas Medical Center.
- Shift from private pay to Medicare model increased procedure volume by 500%.
- TULSA Procedure's MRI-guided precision allows treatment of broader prostate disease spectrum.
- Profound Medical's TULSA-PRO system enables incision-free, real-time MRI-guided prostate therapy.
The big picture
This milestone highlights the strategic advantage of Profound Medical's MRI-guided, incision-free therapy in expanding prostate care options. The success of Texas Prostate's Medicare model demonstrates a scalable approach to increasing procedure volumes, potentially setting a new standard for prostate disease treatment adoption. The ability to treat a broader range of prostate conditions with improved safety profiles positions TULSA-PRO as a disruptive force in the urology sector.
What we're watching
- Adoption Pace
- Whether Texas Prostate's Medicare model can be replicated in other regions to sustain rapid TULSA Procedure growth.
- Competitive Positioning
- How Profound Medical's TULSA-PRO differentiates against traditional prostate cancer treatments like surgery and radiation.
- Regulatory Expansion
- The pace at which Profound Medical can secure additional regulatory approvals for TULSA-PRO in new markets.
Related topics